Connective Tissue Growth Factor Promotes Fibrosis Downstream of TGFb and IL-6 in Chronic Cardiac Allograft Rejection
Open Access
- 24 January 2010
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 10 (2), 220-230
- https://doi.org/10.1111/j.1600-6143.2009.02826.x
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Critical Role for IL-6 in Hypertrophy and Fibrosis in Chronic Cardiac Allograft RejectionAmerican Journal of Transplantation, 2009
- Cardiac Allograft Remodeling After Heart Transplantation Is Associated with Increased Graft Vasculopathy and MortalityAmerican Journal of Transplantation, 2008
- A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathyThe Journal of Experimental Medicine, 2008
- Signaling cross-talk between TGF-β/BMP and other pathwaysCell Research, 2008
- The Classical Complement Pathway in Transplantation: Unanticipated Protective Effects of C1q and Role in Inductive Antibody TherapyAmerican Journal of Transplantation, 2008
- Connective tissue growth factor induces cardiac hypertrophy through Akt signalingBiochemical and Biophysical Research Communications, 2008
- IL-17–dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplantsJCI Insight, 2007
- CCN2 (Connective Tissue Growth Factor) is essential for extracellular matrix production and integrin signaling in chondrocytesJournal of Cell Communication and Signaling, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin α5β1FEBS Letters, 2006